remain confid share rais pt
even chanc catch manag earn
pre-announce guidanc meet increment
bullish share rais sale estim result pt
increas base unchang sale
compani effect grow though channel shift pain say pain
lower asp per patient voluntari confus
libr price pressur longer term gain much higher profit per
patient great strateg shift view frame guidanc
sale growth includ asp headwind channel mix underli
volum growth underli work theori bulk price
headwind felt transmitt receiv revenu line item compani
look keep sensor price high possibl import sever reason
diabet manag part move phone receiv revenu
go away anyway also verili aka dispos transmitt
keep high sensor asp import
scenario play opinion compani success
shift pharmaci brunt asp shift felt
minim asp headwind scenario shift pharmaci goe
slower expect chang payer behavior alway slower expect
asp headwind less would leak
either scenario upsid volum estim opinion compani
still caught suppli side aka still suppli constrain grew
needless say growth next year remain robust
opinion
remain excit pipelin see expand
sensor day day new adhes offer reduc sensor lag time
importantli low cost transmitt back half transmitt beyond
verili product creativ name track back half
launch clearli cadenc product innov remain robust well
final remain plenti runway type intens type
popul year growth compani stop --
trial focus broader type popul discuss around
decis support tool also initi gestat diabet hospit market
longer term initi import opportun valu creation
develop continu glucos monitor diabet manag
price close januari
net cash fulli dilut share
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
thousand except per share
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
